slotkoers
Korea S.E.
00:00:00 08-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
8.770
KRW
|
+0,69%
|
|
+0,57%
|
-14,61%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
251.230
|
229.420
|
542.492
|
404.115
|
256.309
|
284.265
|
Bedrijfswaarde
1 |
147.563
|
116.311
|
437.850
|
294.080
|
155.278
|
242.536
|
K/w-verhouding
|
25
x
|
24,4
x
|
19
x
|
22,6
x
|
12,6
x
|
10,4
x
|
Dividendrendement
|
1,32%
|
1,44%
|
0,92%
|
1,23%
|
1,94%
|
1,75%
|
Marktkapitalisatie/omzet
|
0,82
x
|
0,75
x
|
1,99
x
|
1,38
x
|
0,75
x
|
0,79
x
|
Bedrijfswaarde/omzet
|
0,48
x
|
0,38
x
|
1,61
x
|
1
x
|
0,46
x
|
0,67
x
|
Bedrijfswaarde/EBITDA
|
6,53
x
|
5,44
x
|
13
x
|
8,5
x
|
3,66
x
|
7,45
x
|
Bedrijfswaarde/FCF
|
-32,2
x
|
8,35
x
|
106
x
|
32,6
x
|
243
x
|
-17,3
x
|
FCF Yield
|
-3,1%
|
12%
|
0,94%
|
3,07%
|
0,41%
|
-5,79%
|
Price to Book
|
0,85
x
|
0,76
x
|
1,64
x
|
1,16
x
|
0,7
x
|
0,77
x
|
Aantal aandelen (in duizenden)
|
27.608
|
27.608
|
27.608
|
27.679
|
27.679
|
27.679
|
Referentieprijs
2 |
9.100
|
8.310
|
19.650
|
14.600
|
9.260
|
10.270
|
Datum van publicatie
|
13-03-19
|
11-03-20
|
17-03-21
|
22-03-22
|
15-03-23
|
19-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
306.603
|
307.150
|
272.075
|
293.018
|
340.426
|
361.109
|
EBITDA
1 |
22.586
|
21.367
|
33.785
|
34.591
|
42.424
|
32.562
|
Bedrijfsresultaat (EBIT)
1 |
11.229
|
9.883
|
23.078
|
22.499
|
29.915
|
18.666
|
Operationele Marge
|
3,66%
|
3,22%
|
8,48%
|
7,68%
|
8,79%
|
5,17%
|
Resultaat voor belastingen (EBT)
1 |
14.539
|
16.608
|
33.638
|
26.527
|
23.086
|
36.956
|
Nettowinst (verlies)
1 |
10.069
|
9.402
|
28.508
|
17.870
|
20.383
|
27.438
|
Nettomarge
|
3,28%
|
3,06%
|
10,48%
|
6,1%
|
5,99%
|
7,6%
|
WPA
2 |
364,7
|
340,6
|
1.033
|
646,7
|
736,4
|
991,1
|
Free Cash Flow
1 |
-4.576
|
13.932
|
4.131
|
9.028
|
639,2
|
-14.039
|
FCF-marge
|
-1,49%
|
4,54%
|
1,52%
|
3,08%
|
0,19%
|
-3,89%
|
Kasstroomconversie (ebitda)
|
-
|
65,2%
|
12,23%
|
26,1%
|
1,51%
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
148,17%
|
14,49%
|
50,52%
|
3,14%
|
-
|
Dividend per aandeel
2 |
120,0
|
120,0
|
180,0
|
180,0
|
180,0
|
180,0
|
Datum van publicatie
|
13-03-19
|
11-03-20
|
17-03-21
|
22-03-22
|
15-03-23
|
19-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
103.667
|
113.110
|
104.642
|
110.036
|
101.031
|
41.729
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-4.576
|
13.932
|
4.131
|
9.028
|
639
|
-14.039
|
ROE (netto-inkomsten/eigen vermogen)
|
3,39%
|
3,14%
|
8,92%
|
5,55%
|
5,83%
|
7,17%
|
ROA (netto-inkomsten/totale activa)
|
1,9%
|
1,65%
|
3,56%
|
3,19%
|
4,11%
|
2,27%
|
Totale activa
1 |
529.253
|
568.282
|
800.620
|
560.218
|
495.466
|
1.206.715
|
Nettoactief per aandeel
2 |
10.761
|
10.898
|
11.999
|
12.534
|
13.165
|
13.413
|
Cashflow per aandeel
2 |
1.471
|
1.368
|
2.122
|
2.185
|
1.241
|
2.609
|
Capex
1 |
3.458
|
4.797
|
34.246
|
21.944
|
18.428
|
24.541
|
Capex/omzet
|
1,13%
|
1,56%
|
12,59%
|
7,49%
|
5,41%
|
6,8%
|
Datum van publicatie
|
13-03-19
|
11-03-20
|
17-03-21
|
22-03-22
|
15-03-23
|
19-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -14,61% | 178 mln. | | +20,83% | 43,57 mld. | | +20,70% | 22,7 mld. | | +16,41% | 14,32 mld. | | +11,11% | 13,42 mld. | | +45,91% | 11,83 mld. | | -8,84% | 6,98 mld. | | -0,05% | 6,79 mld. | | -8,87% | 5,73 mld. | | +12,33% | 5,51 mld. |
Generieke geneesmiddelen
|